eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Draft Guidance for Industry on Standards for Clinical Trial Imaging Endpoints; Avalibility
Draft Guidance for Industry on Standards for Clinical Trial Imaging Endpoints; Avalibility
Document ID:
FDA-2011-D-0586-0001
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2011-21244
View Document:
Details Information
Document Subtype:
Notice of Availability
Received Date:
August 19 2011, at 12:00 AM Eastern Daylight Time
Start-End Page:
51993 - 51994
Page Count:
2
Comment Start Date:
August 19 2011, at 12:00 AM Eastern Standard Time
Comment Due Date:
October 18 2011, at 11:59 PM Eastern Standard Time
Comments
View All
Total:
13
Biomedical Systems - Comment
Posted:
10/21/2011
ID:
FDA-2011-D-0586-0004
Comment Period Closed
Oct 18,2011 11:59 PM ET
AstraZeneca - Comment
Posted:
10/21/2011
ID:
FDA-2011-D-0586-0005
Comment Period Closed
Oct 18,2011 11:59 PM ET
Bausch + Lomb - Comment
Posted:
10/21/2011
ID:
FDA-2011-D-0586-0006
Comment Period Closed
Oct 18,2011 11:59 PM ET
Bayer HealthCare LLC - Comment
Posted:
10/21/2011
ID:
FDA-2011-D-0586-0007
Comment Period Closed
Oct 18,2011 11:59 PM ET
Pharma Imaging Group - Comment
Posted:
10/21/2011
ID:
FDA-2011-D-0586-0009
Comment Period Closed
Oct 18,2011 11:59 PM ET
Related Documents
Total:
0
No documents available.
Draft Guidance for Industry on Standards for Clinical Trial Imaging Endpoints; Avalibility
Details Information
Comments
View AllPosted: 10/21/2011 ID: FDA-2011-D-0586-0004
Oct 18,2011 11:59 PM ET
Posted: 10/21/2011 ID: FDA-2011-D-0586-0005
Oct 18,2011 11:59 PM ET
Posted: 10/21/2011 ID: FDA-2011-D-0586-0006
Oct 18,2011 11:59 PM ET
Posted: 10/21/2011 ID: FDA-2011-D-0586-0007
Oct 18,2011 11:59 PM ET
Posted: 10/21/2011 ID: FDA-2011-D-0586-0009
Oct 18,2011 11:59 PM ET
Related Documents